Skip to main content
SD BIOSENSOR INC. logo

SD BIOSENSOR INC. — Investor Relations & Filings

Ticker · 137310 ISIN · KR7137310009 KO Manufacturing
Open in API
Filings indexed 337 across all filing types
Latest filing 2025-03-18 Audit Report / Informat…
Country KR South Korea
Listing KO 137310

About SD BIOSENSOR INC.

https://www.sdbiosensor.com/

SD BIOSENSOR INC. is an in-vitro diagnostics company that develops, manufactures, and supplies point-of-care (POC) diagnostic solutions. The company specializes in rapid diagnostic tests (RDTs), biosensors, and diagnostic reagents aimed at the early and accurate diagnosis, prevention, and management of diseases. A key product is the STANDARD M, a point-of-care molecular diagnostics (MDx) system designed for fast and simple clinical decision-making near the patient. Through its focus on innovative biosensor technology, the company aims to improve the quality of life by providing accessible and reliable diagnostic tools.

Recent filings

Filing Released Lang Actions
사업보고서 (2024.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive 'Consolidated Audit Report' (연결감사보고서) for SD Biosensor, Inc. for the fiscal year ending December 31, 2024. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. This is a formal, full-year financial audit document, which falls under the 'Audit Report / Information' category rather than a general Annual Report (10-K) as it focuses specifically on the audit and financial statements. FY 2024
2025-03-18 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of an upcoming Annual General Meeting (AGM) for SD Biosensor, detailing the meeting date, location, and agenda items such as financial statement approval, director appointments, and dividend-related matters. This is a standard proxy solicitation document used to inform shareholders of the meeting and request their participation/votes. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2025-02-25 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for SD Biosensor, Inc. It details the meeting date, location, agenda items (such as financial statement approval, director appointments, and remuneration limits), and information regarding electronic voting. This document is a standard proxy solicitation material provided to shareholders to inform them of the upcoming meeting and request their participation or proxy vote. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2025-02-25 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 1% confidence The document is a regulatory filing from SD Biosensor regarding a significant change in sales or profit structure (30% or more). It provides preliminary financial data (revenue, operating profit, net income) for the current and previous fiscal years, explicitly stating that these are internal figures subject to change upon final audit. This type of disclosure is a standard regulatory requirement in the Korean market (DART system) for reporting material financial changes before the final annual report is published. It fits the definition of an Earnings Release (ER) as it provides key financial highlights and the reasons for the changes. FY 2024
2025-02-25 Korean
[기재정정]현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 1% confidence The document is a regulatory filing from SD Biosensor regarding a correction to a previously announced cash dividend decision. It details the specific changes in the total dividend amount and the calculation basis (treasury shares). Since the primary purpose is to announce the dividend details and subsequent correction, it falls under the 'Notice of Dividend Amount' category.
2025-02-14 Korean
[기재정정]주식소각결정
Share Issue/Capital Change Classification · 1% confidence The document is a regulatory filing from SD Biosensor regarding a 'Stock Cancellation Decision' (주식 소각 결정). It details the amendment of a previously filed decision, specifically updating the scheduled date for the cancellation of treasury shares. Since this involves the cancellation of shares (a capital change/reduction event), it falls under the category of share-related capital changes.
2025-02-11 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.